RESUMO
Most human sequence variation is in the form of single-nucleotide polymorphisms (SNPs). It has been proposed that coding-region SNPs (cSNPs) be used for direct association studies to determine the genetic basis of complex traits. The success of such studies depends on the frequency of disease-associated alleles, and their distribution in different ethnic populations. If disease-associated alleles are frequent in most populations, then direct genotyping of candidate variants could show robust associations in manageable study samples. This approach is less feasible if the genetic risk from a given candidate gene is due to many infrequent alleles. Previous studies of several genes demonstrated that most variants are relatively infrequent (<0.05). These surveys genotyped small samples (n<75) and thus had limited ability to identify rare alleles. Here we evaluate the prevalence and distribution of such rare alleles by genotyping an ethnically diverse reference sample that is more than six times larger than those used in previous studies (n=450). We screened for variants in the complete coding sequence and intron-exon junctions of two candidate genes for neuropsychiatric phenotypes: SLC6A4, encoding the serotonin transporter; and SLC18A2, encoding the vesicular monoamine transporter. Both genes have unique roles in neuronal transmission, and variants in either gene might be associated with neurobehavioral phenotypes.
Assuntos
Frequência do Gene , Testes Genéticos , Alelos , Primers do DNA , Humanos , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Polimorfismo de Nucleotídeo ÚnicoRESUMO
Carbon monoxide, an activator of guanylyl cyclase, is formed by the action of the enzyme heme oxygenase. By in situ hybridization in brain slices, discrete neuronal localization of messenger RNA for the constitutive form of heme oxygenase throughout the brain has been demonstrated. This localization is essentially the same as that for soluble guanylyl cyclase messenger RNA. In primary cultures of olfactory neurons, zinc protoporphyrin-9, a potent selective inhibitor of heme oxygenase, depletes endogenous guanosine 3',5'-monophosphate (cGMP). Thus, carbon monoxide, like nitric oxide, may be a physiologic regulator of cGMP. These findings, together with the neuronal localizations of heme oxygenase, suggest that carbon monoxide may function as a neurotransmitter.
Assuntos
Encéfalo/enzimologia , Monóxido de Carbono/metabolismo , GMP Cíclico/metabolismo , Heme Oxigenase (Desciclizante)/análise , Neurônios/enzimologia , Neurotransmissores/metabolismo , 5-Aminolevulinato Sintetase/análise , 5-Aminolevulinato Sintetase/genética , Aminoácido Oxirredutases/análise , Aminoácido Oxirredutases/genética , Animais , Animais Recém-Nascidos , Sequência de Bases , Células Cultivadas , Guanilato Ciclase/análise , Guanilato Ciclase/genética , Heme Oxigenase (Desciclizante)/genética , Hibridização In Situ , Dados de Sequência Molecular , NADPH-Ferri-Hemoproteína Redutase/análise , NADPH-Ferri-Hemoproteína Redutase/genética , Óxido Nítrico Sintase , Oligodesoxirribonucleotídeos/química , RNA Mensageiro/análise , RatosRESUMO
Using a cDNA library prepared from circumvallate papillae of rat tongue, we have identified, cloned, and sequenced a novel K+ channel, designated cdrk. The cdrk channel appears to be a member of the Shab subfamily, most closely resembling drk1. Electrophysiologic analysis of expressed cdrk channels reveals delayed rectifier properties similar to those of drk1 channels. Localizations of cdrk mRNA in rat brain and peripheral tissues, assessed by in situ hybridization and Northern blot analysis, differ from any other reported K+ channels. In the brain cdrk mRNA is most concentrated in granule cells of the olfactory bulb and cerebellum. In peripheral tissues, mRNAs for cdrk and drk1 are reciprocally localized, indicating that the K+ channel properties contributed by mammalian Shab homologs may be important in a variety of excitable tissues.
Assuntos
Encéfalo/metabolismo , Canais de Potássio/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Southern Blotting , Clonagem Molecular , DNA/genética , Expressão Gênica , Genes , Ativação do Canal Iônico , Dados de Sequência Molecular , Hibridização de Ácido Nucleico , Oligodesoxirribonucleotídeos/química , Reação em Cadeia da Polimerase , Canais de Potássio/fisiologia , RNA Mensageiro/genética , Ratos , Canais de Potássio Shab , Distribuição TecidualRESUMO
Nitric oxide is a free radical that has been recently recognized as a neural messenger molecule. Nitric oxide synthase has now been purified and molecularly cloned from brain. Using specific antibodies and oligonucleotide probes, we have localized brain nitric oxide synthase to discrete neuronal populations in the rat and primate brain. Nitric oxide synthase is exclusively neuronal, and its localization is absolutely coincident with NADPH diaphorase staining in both rat and primate.
Assuntos
Aminoácido Oxirredutases/metabolismo , Encéfalo/metabolismo , NADPH Desidrogenase/metabolismo , Neurônios/metabolismo , RNA Mensageiro/metabolismo , Aminoácido Oxirredutases/genética , Animais , Western Blotting , Haplorrinos , Imuno-Histoquímica , Masculino , Óxido Nítrico Sintase , Hibridização de Ácido Nucleico , Testes de Precipitina , Ratos , Ratos Endogâmicos , Coloração e Rotulagem , Distribuição TecidualRESUMO
The short-term cardiovascular effects of dynorphin A (1-13), as well as its effects upon morphine bradycardia were investigated. In unanesthetized, unrestrained rats, intracerebroventricular (ICV) dynorphin A (1-13) injections (10-20 micrograms) produced a dose-related pressor effect, whereas intravenous (IV) dynorphin A (1-13) (1.0 mg/kg) produced a depressor effect; these responses persisted less than five min. Heart rate was not significantly altered by these doses or routes of administration. Dynorphin A (1-13) also produced behavioral effects in the unanesthetized animals, such as wet dog shakes in response to IV administration and wet dog shakes accompanied by barrel rolling in response to ICV administration. To evaluate the effects of dynorphin A (1-13) pretreatment on the bradycardic response to IV morphine, rats were pretreated with 10 micrograms dynorphin A (1-13) ICV four, six or eight hours prior to challenge with morphine sulfate (0.1 mg/kg IV). Four hour pretreatment with dynorphin A (1-13) (tested at 14:00 hr) resulted in a potention of morphine bradycardia, with six hours pretreatment (tested at 16:00 hr) no effect was observed, and eight hours following dynorphin A (1-13) pretreatment (tested at 18:00 hr) morphine bradycardia was attenuated. Additionally, the bradycardic response to IV morphine alone became more exaggerated as rats approached their nocturnal activity cycle. These data further establish that dynorphin A (1-13) exerts a potent, long lasting modulatory effect on morphine bradycardia and emphasize the importance of circadian variables in altering the magnitude of cardiovascular responses to opioid agonists.
Assuntos
Pressão Sanguínea/efeitos dos fármacos , Dinorfinas/farmacologia , Frequência Cardíaca/efeitos dos fármacos , Morfina/farmacologia , Fragmentos de Peptídeos/farmacologia , Análise de Variância , Animais , Ritmo Circadiano , Masculino , Ratos , Ratos Endogâmicos , Receptores Opioides/efeitos dos fármacosRESUMO
The putative delta opioid receptor antagonist ICI 174864 (3 mg/kg, i.v.) significantly reversed endotoxic shock hypotension at a dose which lacked significant pressor actions in normotensive, non-endotoxemic rats. In contrast, dynorphin 1-13, when administered either before (0.1 or 1.0 mg/kg, i.v.) or following (1.0 mg/kg, i.v.) injection of endotoxin, failed to alter the course of ensuing circulatory shock. Additionally, pretreatment with dynorphin 1-13 prevented the subsequent reversal of endotoxemic hypotension by ICI 174864. It is concluded that: 1) delta opioid receptors mediate the endogenous opioid component of endotoxic shock hypotension; and 2) functional interactions occur between ligands for mu, delta, and kappa opioid receptor subtypes, which may predict potential interactions with a common macromolecular opioid receptor complex.
Assuntos
Dinorfinas/farmacologia , Encefalina Leucina/análogos & derivados , Fragmentos de Peptídeos/farmacologia , Choque Séptico/tratamento farmacológico , Animais , Pressão Sanguínea/efeitos dos fármacos , Encefalina Leucina/farmacologia , Masculino , Ratos , Ratos Endogâmicos , Receptores Opioides/efeitos dos fármacos , Receptores Opioides/fisiologia , Receptores Opioides delta , Receptores Opioides kappaRESUMO
There has been a dramatic rise in gene x environment studies of human behavior over the past decade that have moved the field beyond simple nature versus nurture debates. These studies offer promise in accounting for more variability in behavioral and biological phenotypes than studies that focus on genetic or experiential factors alone. They also provide clues into mechanisms of modifying genetic risk or resilience in neurodevelopmental disorders. Yet, it is rare that these studies consider how these interactions change over the course of development. In this paper, we describe research that focuses on the impact of a polymorphism in a brain-derived neurotrophic factor (BDNF) gene, known to be involved in learning and development. Specifically we present findings that assess the effects of genotypic and environmental loadings on neuroanatomic and behavioral phenotypes across development. The findings illustrate the use of a genetic mouse model that mimics the human polymorphism, to constrain the interpretation of gene-environment interactions across development in humans.
Assuntos
Envelhecimento/genética , Fator Neurotrófico Derivado do Encéfalo/genética , Meio Ambiente , Modelos Genéticos , Animais , Encéfalo/crescimento & desenvolvimento , Encéfalo/metabolismo , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Desenvolvimento Humano , Humanos , Camundongos , Fenótipo , Polimorfismo GenéticoRESUMO
The neurotransmitter dopamine acts through various receptor subtypes that are largely associated with enhancement or inhibition of adenylyl cyclases. These dopamine-sensitive adenylyl cyclases are highly concentrated in the corpus stratum and associated limbic structures of the brain, where their levels exceed by orders of magnitude those in other areas of the brain. Here we use in situ hybridization to show that messenger RNA for three of these adenylyl cyclases is not found in the corpus striatum. We have isolated and expressed a complementary DNA encoding new adenylyl cyclase whose selective concentration in the corpus striatum indicates that it may be responsible for the synaptic actions of dopamine.
Assuntos
Adenilil Ciclases/genética , Corpo Estriado/enzimologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Northern Blotting , Clonagem Molecular , Coenzimas/genética , Colforsina/farmacologia , Expressão Gênica , Hibridização In Situ , Dados de Sequência Molecular , RNA Mensageiro/análise , RatosRESUMO
mRNAs for isozymes of phospholipase C (PLC) were localized in rat brain by in situ hybridization with oligonucleotide probes for PLC isozymes I, II, and III of Rhee's group [Suh, P.-G., Ryu, S. H., Moon, K. H., Suh, H. W. & Rhee, S. G. (1988) Proc. Natl. Acad. Sci. USA 85, 5419-5423 and (1988) Cell 54, 161-169], and isozyme I of Bennett and Crooke [Bennett, C. F., Balcarek, J. M., Varrichio, A. & Crooke, S. T. (1988) Nature (London) 334, 268-270], which we designate PLC-A. The isozymes displayed different localizations. PLC-A mRNA was highest in the mitral cell layer of the olfactory bulb, choroid plexus, hippocampus and dentate gyrus, magnocellular hypothalamic nuclei, rostral raphe nuclei, and cerebellar Purkinje cells. PLC-I was highest in the internal granular cell layer of the olfactory bulb, cerebral cortex, caudate, nucleus of the lateral olfactory tract, reticular nucleus of thalamus, hippocampus and dentate gyrus, and granule cell layer of the cerebellum. PLC-II had a more widespread distribution, with relatively high levels in the internal granular layer of the olfactory bulb, hippocampus and dentate gyrus, and cerebellar Purkinje and granule cells. PLC-III label was low throughout the brain. These distributions suggest selective coupling of individual PLC isozymes with particular postsynaptic receptors. PLC-A may be preferentially associated with 5-hydroxytryptamine 1C receptors, vasopressin V1 receptors, and a subtype of glutamate receptors. PLC-I may be linked to muscarinic m1 and m3 receptors as well as other receptors. The distribution of PLC-II mRNA resembles that of src protooncogene, with which it displays sequence homology.
Assuntos
Encéfalo/enzimologia , Isoenzimas/genética , Fosfolipases Tipo C/genética , Animais , Hibridização de Ácido Nucleico , Fosfatidilinositóis/fisiologia , RNA , Sondas RNA , RNA Antissenso , RNA Mensageiro/metabolismo , Ratos/embriologiaRESUMO
BACKGROUND: Clozapine, the classic atypical neuroleptic, exerts therapeutic actions in schizophrenic patients unresponsive to most neuroleptics. Clozapine interacts with numerous neurotransmitter receptors, and selective actions at novel subtypes of dopamine and serotonin receptors have been proposed to explain clozapine's unique psychotropic effects. To identify sites with which clozapine preferentially interacts in a therapeutic setting, we have characterized clozapine binding to brain membranes. MATERIALS AND METHODS: [3H]Clozapine binding was examined in rat brain membranes as well as cloned-expressed 5-HT6 serotonin receptors. RESULTS: [3H]Clozapine binds with low nanomolar affinity to two distinct sites. One reflects muscarinic receptors consistent with the drug's anticholinergic actions. The drug competition profile of the second site most closely resembles 5HT6 serotonin receptors, though serotonin itself displays low affinity. [3H]Clozapine binding levels are similar in all brain regions examined with no concentration in the corpus striatum. CONCLUSIONS: Besides muscarinic receptors, clozapine primarily labels sites with properties resembling 5HT6 serotonin receptors. If this is also the site with which clozapine principally interacts in intact human brain, it may account for the unique beneficial actions of clozapine and other atypical neuroleptics, and provide a molecular target for developing new, safer, and more effective agents.
Assuntos
Antipsicóticos/metabolismo , Encéfalo/metabolismo , Clozapina/metabolismo , Receptores Muscarínicos/metabolismo , Receptores de Serotonina/metabolismo , Animais , Sítios de Ligação , Linhagem Celular , Membrana Celular/metabolismo , Humanos , Ensaio Radioligante , Ratos , Ratos Sprague-Dawley , Receptores Dopaminérgicos/metabolismo , Proteínas Recombinantes/metabolismoRESUMO
Nitric oxide is a messenger molecule, mediating the effect of endothelium-derived relaxing factor in blood vessels and the cytotoxic actions of macrophages, and playing a part in neuronal communication in the brain. Cloning of a complementary DNA for brain nitric oxide synthase reveals recognition sites for NADPH, FAD, flavin mononucleotide and calmodulin as well as phosphorylation sites, indicating that the synthase is regulated by many different factors. The only known mammalian enzyme with close homology is cytochrome P-450 reductase.
Assuntos
Aminoácido Oxirredutases/genética , Clonagem Molecular , Expressão Gênica , NADPH-Ferri-Hemoproteína Redutase/genética , Aminoácido Oxirredutases/química , Aminoácido Oxirredutases/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Sítios de Ligação , Calmodulina/metabolismo , Linhagem Celular , Cerebelo/enzimologia , DNA/genética , Mononucleotídeo de Flavina/metabolismo , Flavina-Adenina Dinucleotídeo/metabolismo , Humanos , Dados de Sequência Molecular , NADP/metabolismo , Óxido Nítrico Sintase , Fosforilação , RNA Mensageiro/análise , RNA Mensageiro/genética , Ratos , Homologia de Sequência do Ácido Nucleico , Distribuição Tecidual , TransfecçãoRESUMO
The type 1 metabotropic glutamate receptor (mGluR1) is through to act via the phosphoinositide (PI) system with the associated formation of inositol 1,4,5-trisphosphate (IP3) and Ca2+ release. Utilizing immunohistochemistry and in situ hybridization, we have localized protein and mRNA, respectively, for the mGluR1 and the IP3 receptor (IP3R). We have also localized glutamate-linked PI turnover by autoradiography with 3H-cytidine. We observe a striking contrast in localizations of mGluR1 and IP3R both for protein and mRNA. For instance, mGluR1 occurs in the apparent absence of IP3R in neurons of the stratum oriens of the CA1 hippocampus, islands of Calleja, anterodorsal nucleus of thalamus, lateral nucleus of hypothalamus, and the granular cell layer and the deep nuclei of cerebellum. mGluR1 actions in these brain regions may primarily be mediated through the protein kinase C limb of the PI system, as they contain moderate amounts of 3H-phorbol ester binding. The subthalamic nucleus, red nucleus, and Darkshevich's nucleus, which possess high levels of mGluR1, are devoid of both IP3R immunoreactivity and 3H-phorbol ester binding. These reciprocal localizations suggest that mGluR1 actions in many brain areas may not primarily involve IP3, reflecting instead influences on protein kinase C or other second messengers.
Assuntos
Encéfalo/metabolismo , Canais de Cálcio , Fosfatidilinositóis/metabolismo , Receptores de Superfície Celular/metabolismo , Receptores Citoplasmáticos e Nucleares , Receptores de Glutamato/metabolismo , Animais , Encéfalo/ultraestrutura , Cicloleucina/análogos & derivados , Cicloleucina/farmacologia , Imuno-Histoquímica , Hibridização In Situ , Receptores de Inositol 1,4,5-Trifosfato , Masculino , Microscopia Eletrônica , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos , Receptores de Superfície Celular/genética , Distribuição TecidualRESUMO
The immunophilins cyclophilin and FK506 binding protein (FKBP) are small, predominantly soluble proteins that bind the immunosuppressant drugs cyclosporin A and FK506, respectively, with high affinity, and which seem to mediate their pharmacological actions. The Ca(2+)-dependent protein phosphatase, calcineurin, binds the cyclophilin-cyclosporin A and FKBP-FK506 complexes, indicating that calcineurin might mediate the actions of these drugs. A physiological role for the immunophilins in the nervous system is implied by a close homology between the structure of NINA A, a protein in the neural retina of Drosophila, and cyclophilin, as well as by the high density of FKBP messenger RNA in brain tissue. Here we report that the levels of FKBP and mRNA in rat brain are extraordinarily high and that their regional localization is virtually identical to that of calcineurin, indicating that there may be a physiological link between calcineurin and the immunophilins. We also show that at low concentrations FK506 and cyclosporin A enhance the phosphorylation of endogenous protein substrates in brain tissue and in intact PC12 cells, indicating that these drugs may inhibit phosphatase activity by interacting with the immunophilin-calcineurin complexes.
Assuntos
Encéfalo/metabolismo , Proteínas de Ligação a Calmodulina/metabolismo , Proteínas de Transporte/metabolismo , Ciclosporina/metabolismo , Fosfoproteínas Fosfatases/metabolismo , Tacrolimo/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Autorradiografia , Encéfalo/anatomia & histologia , Calcineurina , Cálcio/farmacologia , Proteínas de Ligação a Calmodulina/análise , Proteínas de Transporte/análise , Membrana Celular/metabolismo , Peso Molecular , Especificidade de Órgãos , Células PC12 , Fosfoproteínas Fosfatases/análise , Fosforilação , Ratos , Radioisótopos de Enxofre , Proteínas de Ligação a Tacrolimo , Acetato de Tetradecanoilforbol/farmacologia , TrítioRESUMO
We have searched for genes predisposing to bipolar disorder (BP) by studying individuals with the most extreme form of the affected phenotype, BP-I, ascertained from the genetically isolated population of the Central Valley of Costa Rica (CVCR). The results of a previous linkage analysis on two extended CVCR BP-I pedigrees, CR001 and CR004, and of linkage disequilibrium (LD) analyses of a CVCR population sample of BP-I patients implicated a candidate region on 18p11.3. We further investigated this region by creating a physical map and developing 4 new microsatellite and 26 single-nucleotide polymorphism markers for typing in the pedigree and population samples. We report the results of fine-scale association analyses in the population sample, as well as evaluation of haplotypes in pedigree CR001. Our results suggest a candidate region containing six genes but also highlight the complexities of LD mapping of common disorders.